The authorization to launch Sunharbo in China is the first approval worldwide for a new class of blood-thinning medicines.

Discover how the herbal medicine Kyunghee Cheonghyeoldan, backed by over 20 years of research, aids in stroke prevention and ...

Parasol Med Tech has closed an oversubscribed $2.75 million pre-seed funding round to advance development of its ...

The once-daily, oral Factor XIa (FXIa) inhibitor, available at a dose of 50 mg, is indicated to reduce the risk of stroke in ...

Stroke prevention is not about fearing your phone. It is about protecting sleep, staying active and managing established risk ...

Bayer secures China’s first global approval for Sunharbo, a Factor XIa inhibitor designed to reduce recurrent stroke risk.

Stay active most days of the week: A brisk walk around your neighborhood, a morning stretch routine or water aerobics can ...

MGM Healthcare has performed approximately 100 brain bypass surgeries on adults with mild strokes or early warning signs of ...

A retrospective cohort study of 300 elderly stroke patients with atrial fibrillation found that model-estimated warfarin ...

A large international study suggests that episodes of anger and sudden strenuous activity can be linked to a stroke occurring ...

MGM Healthcare takes a giant step in stroke prevention, having successfully performed about 100 brain bypass surgeries on ...